Allergic rhinitis in children
Conditions
Interventions
Combination therapy group:Huaiqihuang granules combined with a nasal corticosteroid preparation for the treatment of allergic rhinitis with a course of treatment of >=4 weeks
Control group:Patients with allergic rhinitis treated with nasal corticosteroid preparations for a duration of >= 4 weeks
Sponsors
Chengdu Women's and Children's Central Hospital
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: Children who meets the diagnostic criteria for allergic rhinitis according to the child's family history and typical allergy history, clinical manifestations, and a series of laboratory tests ; age range 2 to 12 years old; Point prick test found >= 1 allergen; Obtained the right to informed consent from the guardian; Patients who receive nasal corticosteroid preparations in their medication treatment plan and have a treatment duration of >= 4 weeks; The combination therapy group must meet the following requirements: the drug treatment plan includes both nasal corticosteroid preparations and Huaiqihuang granules, and the combination therapy course is >= 4 weeks.
Exclusion criteria
Exclusion criteria: Patients has other comorbidities; Have undergone relevant disease surgeries before the study; Individuals who are allergic to the drugs used in this study; Those who cannot follow the rules of medical advice for treatment; After inclusion, it was found that the product did not meet the requirements and was mistakenly accepted; Not treated as required; Unable to conduct data collection and efficacy evaluation normally; Those who have poor medication adherence and continue treatment after treatment interruption; Those who have not undergone relevant symptom scoring and immune index testing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate;Recurrence rate; | — |
Countries
China
Contacts
Public ContactYi Deng
Chengdu Women's and Children's Central Hospital
Outcome results
None listed